NDC 0006-5003 Prevymis
Letermovir Injection, Solution Intravenous
Product Information
Product Characteristics
Color(s) | YELLOW (C48330) PINK (C48328) |
Shape | OVAL (C48345) |
Size(s) | 17 MM 21 MM |
Imprint(s) | 591 595 |
Score | 1 |
Product Packages
NDC Code 0006-5003-01
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON / 12 mL in 1 VIAL, SINGLE-DOSE (0006-5003-02)
Product Details
What is NDC 0006-5003?
The NDC code 0006-5003 is assigned by the FDA to the product Prevymis which is a human prescription drug product labeled by Merck Sharp & Dohme Llc. The generic name of Prevymis is letermovir. The product's dosage form is injection, solution and is administered via intravenous form. The product is distributed in a single package with assigned NDC code 0006-5003-01 1 vial, single-dose in 1 carton / 12 ml in 1 vial, single-dose (0006-5003-02). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
What are the uses for Prevymis?
This medication is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received a bone marrow transplant. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Letermovir is an anti-viral drug. It works by stopping the growth of the virus.
What are Prevymis Active Ingredients?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
Which are Prevymis UNII Codes?
The UNII codes for the active ingredients in this product are:
- LETERMOVIR (UNII: 1H09Y5WO1F)
- LETERMOVIR (UNII: 1H09Y5WO1F) (Active Moiety)
Which are Prevymis Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- POVIDONE K25 (UNII: K0KQV10C35)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- HYDROXYPROPYL BETADEX (UNII: 1I96OHX6EK)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Prevymis?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 1988652 - letermovir 240 MG in 12 ML Injection
- RxCUI: 1988652 - 12 ML letermovir 20 MG/ML Injection
- RxCUI: 1988652 - letermovir 20 MG/ML per 12 ML Injection
- RxCUI: 1988652 - letermovir 240 MG per 12 ML Injection
- RxCUI: 1988657 - PREVYMIS 240 MG in 12 ML Injection
Which are the Pharmacologic Classes for Prevymis?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
- Cytochrome P450 2C19 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 2C8 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- Cytomegalovirus DNA Terminase Complex Inhibitor - [EPC] (Established Pharmacologic Class)
- DNA Terminase Complex Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B3 Inhibitors - [MoA] (Mechanism of Action)
* Please review the disclaimer below.
Patient Education
Letermovir Injection
Letermovir injection is used to help prevent cytomegalovirus (CMV) infection and disease in certain people who have received a hematopoietic stem-cell transplant (HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow) and are at increased risk of developing a CMV infection. Letermovir is in a class of medications called antivirals. It works by slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.
Product Label
We have moved the product label and warning information to a dedicated page, please follow the link below:
View Product Label